BI 10773 add-on to Metformin in Patients With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

495

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

October 31, 2009

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

BI 10773

DRUG

placebo

DRUG

sitagliptin

Trial Locations (116)

Unknown

1245.10.10026 Boehringer Ingelheim Investigational Site, Chula Vista

1245.10.10001 Boehringer Ingelheim Investigational Site, Mission Viejo

1245.10.10011 Boehringer Ingelheim Investigational Site, Pasadena

1245.10.10028 Boehringer Ingelheim Investigational Site, Spring Valley

1245.10.10027 Boehringer Ingelheim Investigational Site, Walnut Creek

1245.10.10004 Boehringer Ingelheim Investigational Site, Clearwarter

1245.10.10021 Boehringer Ingelheim Investigational Site, Melbourne

1245.10.10005 Boehringer Ingelheim Investigational Site, Miami

1245.10.10019 Boehringer Ingelheim Investigational Site, Miami

1245.10.10024 Boehringer Ingelheim Investigational Site, Saint Cloud

1245.10.10014 Boehringer Ingelheim Investigational Site, Roswell

1245.10.10016 Boehringer Ingelheim Investigational Site, Staten Island

1245.10.10009 Boehringer Ingelheim Investigational Site, Shelby

1245.10.10006 Boehringer Ingelheim Investigational Site, Wadsworth

1245.10.10023 Boehringer Ingelheim Investigational Site, Norristown

1245.10.10010 Boehringer Ingelheim Investigational Site, Clemson

1245.10.10015 Boehringer Ingelheim Investigational Site, Dallas

1245.10.10012 Boehringer Ingelheim Investigational Site, Temple

1245.10.10025 Boehringer Ingelheim Investigational Site, Federal Way

1245.10.54002 Boehringer Ingelheim Investigational Site, Capital Federal

1245.10.54004 Boehringer Ingelheim Investigational Site, Capital Federal

1245.10.54008 Boehringer Ingelheim Investigational Site, Capital Federal

1245.10.54006 Boehringer Ingelheim Investigational Site, Mar del Plata

1245.10.54005 Boehringer Ingelheim Investigational Site, Mendoza

1245.10.43002 Boehringer Ingelheim Investigational Site, Graz

1245.10.43004 Boehringer Ingelheim Investigational Site, Innsbruck

1245.10.43001 Boehringer Ingelheim Investigational Site, Vienna

1245.10.43003 Boehringer Ingelheim Investigational Site, Vienna

1245.10.42003 Boehringer Ingelheim Investigational Site, Brno

1245.10.42005 Boehringer Ingelheim Investigational Site, Brno

1245.10.42001 Boehringer Ingelheim Investigational Site, Břeclav

1245.10.42002 Boehringer Ingelheim Investigational Site, Hodonín

1245.10.37201 Boehringer Ingelheim Investigational Site, Tallinn

1245.10.37202 Boehringer Ingelheim Investigational Site, Tartu

1245.10.58006 Boehringer Ingelheim Investigational Site, Kerava

1245.10.58003 Boehringer Ingelheim Investigational Site, Oulu

1245.10.58004 Boehringer Ingelheim Investigational Site, Tampere

1245.10.58001 Boehringer Ingelheim Investigational Site, Turku

1245.10.3302A Boehringer Ingelheim Investigational Site, Bondy

1245.10.3302B Boehringer Ingelheim Investigational Site, Bondy

1245.10.3310A Boehringer Ingelheim Investigational Site, Caen

1245.10.3310B Boehringer Ingelheim Investigational Site, Caen

1245.10.3310C Boehringer Ingelheim Investigational Site, Caen

1245.10.3301A Boehringer Ingelheim Investigational Site, Corbeil-Essonnes

1245.10.3301B Boehringer Ingelheim Investigational Site, Corbeil-Essonnes

1245.10.3303A Boehringer Ingelheim Investigational Site, La Rochelle

1245.10.3303B Boehringer Ingelheim Investigational Site, La Rochelle

1245.10.3303C Boehringer Ingelheim Investigational Site, La Rochelle

1245.10.3303D Boehringer Ingelheim Investigational Site, La Rochelle

1245.10.3308A Boehringer Ingelheim Investigational Site, Le Grau-du-Roi

1245.10.3308B Boehringer Ingelheim Investigational Site, Le Grau-du-Roi

1245.10.3309A Boehringer Ingelheim Investigational Site, Nanterre

1245.10.3306A Boehringer Ingelheim Investigational Site, Narbonne

1245.10.3306B Boehringer Ingelheim Investigational Site, Narbonne

1245.10.3307A Boehringer Ingelheim Investigational Site, Quimper

1245.10.3304A Boehringer Ingelheim Investigational Site, Reims

1245.10.3304B Boehringer Ingelheim Investigational Site, Reims

1245.10.3304C Boehringer Ingelheim Investigational Site, Reims

1245.10.3311A Boehringer Ingelheim Investigational Site, Saint-Mandé

1245.10.3311B Boehringer Ingelheim Investigational Site, Saint-Mandé

1245.10.3311C Boehringer Ingelheim Investigational Site, Saint-Mandé

1245.10.3311D Boehringer Ingelheim Investigational Site, Saint-Mandé

1245.10.3305A Boehringer Ingelheim Investigational Site, Valenciennes

1245.10.3305B Boehringer Ingelheim Investigational Site, Valenciennes

1245.10.3305C Boehringer Ingelheim Investigational Site, Valenciennes

1245.10.3305D Boehringer Ingelheim Investigational Site, Valenciennes

1245.10.49001 Boehringer Ingelheim Investigational Site, Erlangen

1245.10.49003 Boehringer Ingelheim Investigational Site, Frankfurt

1245.10.49002 Boehringer Ingelheim Investigational Site, Hamburg

1245.10.49004 Boehringer Ingelheim Investigational Site, Rehlingen-Siersburg

1245.10.36001 Boehringer Ingelheim Investigational Site, Budapest

1245.10.36003 Boehringer Ingelheim Investigational Site, Budapest

1245.10.36004 Boehringer Ingelheim Investigational Site, Budapest

1245.10.36005 Boehringer Ingelheim Investigational Site, Győr

1245.10.36002 Boehringer Ingelheim Investigational Site, Szombathely

1245.10.37101 Boehringer Ingelheim Investigational Site, Daugavpils

1245.10.37105 Boehringer Ingelheim Investigational Site, Kuldīga

1245.10.37106 Boehringer Ingelheim Investigational Site, Ogre

1245.10.37103 Boehringer Ingelheim Investigational Site, Riga

1245.10.37107 Boehringer Ingelheim Investigational Site, Riga

1245.10.37102 Boehringer Ingelheim Investigational Site, Talsi

1245.10.37104 Boehringer Ingelheim Investigational Site, Valmiera

1245.10.47004 Boehringer Ingelheim Investigational Site, Ålesund

1245.10.47003 Boehringer Ingelheim Investigational Site, Hamar

1245.10.47005 Boehringer Ingelheim Investigational Site, Oslo

1245.10.47001 Boehringer Ingelheim Investigational Site, Stavanger

1245.10.40001 Boehringer Ingelheim Investigational Site, Alba Iulia

1245.10.40005 Boehringer Ingelheim Investigational Site, Baia Mare Maramures

1245.10.40003 Boehringer Ingelheim Investigational Site, Brasov

1245.10.40002 Boehringer Ingelheim Investigational Site, Bucharest

1245.10.40007 Boehringer Ingelheim Investigational Site, Bucharest

1245.10.40004 Boehringer Ingelheim Investigational Site, Galati

1245.10.40006 Boehringer Ingelheim Investigational Site, Satu Mare

1245.10.70001 Boehringer Ingelheim Investigational Site, Moscow

1245.10.70002 Boehringer Ingelheim Investigational Site, Moscow

1245.10.70003 Boehringer Ingelheim Investigational Site, Moscow

1245.10.70004 Boehringer Ingelheim Investigational Site, Saint Petersburg

1245.10.70005 Boehringer Ingelheim Investigational Site, Saint Petersburg

1245.10.70006 Boehringer Ingelheim Investigational Site, Saint Petersburg

1245.10.70007 Boehringer Ingelheim Investigational Site, Saratov

1245.10.62003 Boehringer Ingelheim Investigational Site, Bratislava

1245.10.62001 Boehringer Ingelheim Investigational Site, Nitra

1245.10.62002 Boehringer Ingelheim Investigational Site, Nitra

1245.10.62004 Boehringer Ingelheim Investigational Site, Prešov

1245.10.34002 Boehringer Ingelheim Investigational Site, Barcelona

1245.10.34001 Boehringer Ingelheim Investigational Site, Girona

1245.10.34010 Boehringer Ingelheim Investigational Site, L'Hospitalet de Llobregat (Barcelona)

1245.10.34004 Boehringer Ingelheim Investigational Site, Málaga

1245.10.34005 Boehringer Ingelheim Investigational Site, Palma (Mallorca)

1245.10.34006 Boehringer Ingelheim Investigational Site, Palma de Mallorca

1245.10.34008 Boehringer Ingelheim Investigational Site, Santander

1245.10.38002 Boehringer Ingelheim Investigational Site, Dnipro

1245.10.38004 Boehringer Ingelheim Investigational Site, Kharkiv

1245.10.38005 Boehringer Ingelheim Investigational Site, Kharkiv

1245.10.38003 Boehringer Ingelheim Investigational Site, Kiev

1245.10.38001 Boehringer Ingelheim Investigational Site, Vinnitsa

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00749190 - BI 10773 add-on to Metformin in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter